Matthew P. Salerno’s practice focuses on corporate and financial transactions, particularly public and private mergers and acquisitions, private equity investments, and contests for corporate control.

Matthew joined the firm in 2001 and became a partner in 2010.

Notable Experiences

  • Advent International and Warburg Pincus in their $4.25 billion acquisition of BioPharma Solutions.

  • Summit Health-CityMD, a Warburg Pincus portfolio company, in its $8.9 billion sale to VillageMD.

  • Astound Broadband in its $8.1 billion sale to Stonepeak Infrastructure Partners.

  • Hygiena, a portfolio company of Warburg Pincus, in its acquisition of DuPont’s global food safety diagnostic business.

  • The Coca-Cola Company on the combination of the businesses of three entities to form a new Western European bottler to be called Coca-Cola European Partners, creating the world’s largest independent bottler of Coca-Cola products.

  • Google in its $12.5 billion acquisition of Motorola Mobility; in its acquisitions of Quickoffice, DeepMind Technologies, Wildfire Interactive and Skybox Imaging; and in its pending sale of Skybox Imaging (now known as Planet Labs).

  • Western Digital in its $19 billion acquisition of Sandisk; its divestiture transaction in connection with obtaining regulatory clearance for its $4.8 billion acquisition of Viviti Technologies; and its acquisition of Amplidata.

  • Endurance International Group, a portfolio company of Warburg Pincus, in its acquisitions of Constant Contact, and of the websites business of Intuit.

  • Warburg Pincus in its acquisitions of Wencor Group, Electronic Funds Source, CROSSMARK Holdings and Endurance International Group, in its acquisition of a majority of Sterigenics, and in its subsequent sale of Electronic Funds Source.

  • Medtronic in a range of significant transactions, including its:

    • $49.9 billion acquisition of Covidien.
    • $800 million acquisition of Ardian.
    • $500 million acquisition of Invatec and two related companies, Fogazzi and KRAUTH Cardio-Vascular.
    • $3.9 billion acquisition of Kyphon.
  • GT Nexus in its $675 million acquisition by Infor.

  • Envision Pharmaceutical Holdings in its acquisition of Laker Software for cash and an equity stake in Envision.

  • TPG in its acquisition of Envision Pharmaceuticals Holdings and its complementary businesses including Envision Insurance Company, Envision Medical Solutions, Orchard Pharmaceutical Services and Design Rx.

See More